These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20737641)

  • 41. Free drug metabolic clearance in elderly people.
    Butler JM; Begg EJ
    Clin Pharmacokinet; 2008; 47(5):297-321. PubMed ID: 18399712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of drug-protein binding parameters on assuming the validity of thermodynamic equilibrium.
    Soltés L; Mach M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):113-9. PubMed ID: 11939544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonlinear Protein Binding: Not What You Think.
    Deitchman AN; Singh RSP; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1754-1760. PubMed ID: 29626534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and analysis of protein binding experiments.
    Khan AZ; Aarons L
    J Theor Biol; 1989 Sep; 140(2):145-66. PubMed ID: 2615394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.
    Hervé F; Urien S; Albengres E; Duché JC; Tillement JP
    Clin Pharmacokinet; 1994 Jan; 26(1):44-58. PubMed ID: 8137597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetic analysis of drug-protein interactions by affinity chromatography.
    Bi C; Beeram S; Li Z; Zheng X; Hage DS
    Drug Discov Today Technol; 2015 Oct; 17():16-21. PubMed ID: 26724332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of free drug in phase I: is it useful?
    Barré J; Riant P; Tillement JP
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():141s-150s. PubMed ID: 2093625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins.
    Blakeley D; Sykes DA; Ensor P; Bertran E; Aston PJ; Charlton SJ
    Br J Pharmacol; 2015 Nov; 172(21):5037-49. PubMed ID: 26211929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States.
    Celestin MN; Musteata FM
    J Pharm Sci; 2021 Oct; 110(10):3331-3344. PubMed ID: 34089711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate.
    Berezhkovskiy LM
    J Pharm Sci; 2012 May; 101(5):1909-16. PubMed ID: 22331662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free drug percentage of moxidectin declines with increasing concentrations in the serum of marsupials.
    Stott EK; Nie S; Williamson NA; Skerratt LF
    Int J Parasitol Parasites Wildl; 2024 Apr; 23():100899. PubMed ID: 38274349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calculation of normalized drug concentrations in the presence of altered plasma protein binding.
    Musteata FM
    Clin Pharmacokinet; 2012 Jan; 51(1):55-68. PubMed ID: 22149258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the influence of protein binding on pharmacological activity of drugs.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consideration of the linear concentration increase of the unbound drug fraction in plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):383-93. PubMed ID: 18704923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the possibility of self-induction of drug protein binding.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Oct; 99(10):4400-5. PubMed ID: 20737641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentration-dependent plasma protein binding: Expect the unexpected.
    Nation RL; Theuretzbacher U; Tsuji BT;
    Eur J Pharm Sci; 2018 Sep; 122():341-346. PubMed ID: 30026170
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.